"Lumere’s analysis of evidence available in the literature is impressive, and when they combine that with our data, it gives us the insight we need to address utilization issues before they become serious problems.“
—Director of Pharmacy, Asante
Constantly rising prescription drug prices—often unrelated to a medication’s actual value or demonstrated outcomes—are compromising hospitals’ ability to deliver value-based care while remaining competitive.
Lumere’s Pharmacy Solutions bring medication management to an entirely new level by applying evidence-based, clinically relevant information to your data—providing you with actionable strategies for solving drug spend and utilization challenges.
Drug Evidence Library
Lumere’s drug evidence library gives access to information on thousands of drug profiles, drug groups, and in-depth literature reviews. Every drug evidence report employs an exhaustive review of therapeutic alternatives, including an evaluation of peer-reviewed literature and ongoing clinical trials. Additionally, our research includes the review of non-published evidence, such as preliminary trial results often reported through conference proceedings, terminated clinical trials, and clinical trial results submitted to the FDA during the product approval process in order to highlight any potential publication bias.
Our research library enables hospital pharmacy teams to efficiently perform the following:
Utilization Management transforms your organization’s spend and utilization from disparate data sources combining it with the relevant clinical evidence. Our indication-based drug analyses and evidence-based strategies enable health systems to identify and prioritize clinically-relevant opportunities that reduce costs without compromising quality.
Our analytics enables hospital pharmacy teams to quickly gain insights into the following:
Lumere’s drug strategy library combines your organization’s spend and utilization information with the clinical research recommendations to provide a financial savings forecast. Based on the clinical research, our drug strategy library identifies actions for cost-saving considerations.
P&T Workflow: Lumere Requests, Projects & Committees
Processes to manage P&T are notoriously fragmented and inefficient. Fortunately, the Lumere solution provides an antidote to unsystematic evaluation protocols: Workflow. Workflow ensures that clinician product requests are streamlined and that all of your teams and committees are rigorously conducting the right analyses to make appropriate decisions.
Working in tandem with Lumere's research and analytical capabilities, Workflow acts as a centralized tool for overseeing and/or engaging with P&T tasks. When a clinician requests a medical device or drug, the product can be immediately approved, rejected, or assigned to a project for further evaluation.
The Workflow capability allows you to:
Workflow is categorized into three components: requests, projects, and committees. Regarding the evaluation process, the ideal Workflow methodology can be summed up the following way:
Lumere is focused on accelerating health system efforts to eliminate unwarranted variation and waste. Our support model is designed to ensure users are leveraging the capabilities of our technology and the expert resources available at Lumere. Each client is assigned a Dedicated Advisor and Executive Partner to ensure your organization is deriving maximum value from the partnership.